Cited by 144Per- and polyfluoroalkyl substances researchToxic Organic Pollutants ImpactEffects and risks of endocrine disrupting chemicals

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Development of Pbpk Models for Pfoa and Pfos for Human Pregnancy and Lactation Life Stages

Open access

Loccisano, Anne E., Longnecker, Matthew P., Campbell, Jerry L., Andersen, Melvin E., Clewell, Harvey J.·2013·Journal of Toxicology and Environmental Health, Part A

DOI 10.1080/15287394.2012.722523PMC PMC3502013

Open this paper in CoChat — free account

Abstract

Perfluoroalkyl acid carboxylates and sulfonates (PFAA) have many consumer and industrial applications. Developmental toxicity studies in animals have raised concern about potential reproductive/developmental effects of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS); however, in humans conflicting results have been reported for associations between maternal PFAA levels and these outcomes. Risk assessments and interpretation of available human data during gestation and lactation are hindered due to lack of a framework for understanding and estimating maternal, fetal, and neonatal pharmacokinetics (PK). Physiologically based pharmacokinetic (PBPK) models were developed for PFOA and PFOS for the gestation and lactation life stages in humans to understand how the physiological changes associated with development affect pharmacokinetics of these compounds in the mother, fetus, and infant. These models were derived from PBPK models for PFOA/PFOS that were previously developed for adult humans and rats during gestation and lactation and from existing human pregnancy and lactation models developed for other chemicals. The models simulated PFOA and PFOS concentrations in fetal, infant, and maternal plasma and milk, were compared to available data in humans, and also were used to estimate maternal exposure. The models reported here identified several research needs, which include (1) the identification of transporters involved in renal resorption to explain the multiyear half-lives of these compounds in humans, (2) factors affecting clearance of PFOA/PFOS during gestation and lactation, and (3) data to estimate clearance of PFOA/PFOS in infants. These models may help address concerns regarding possible adverse health effects due to PFOA/PFOS exposure in the fetus and infant and may be useful in comparing pharmacokinetics across life stages.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1080/15287394.2012.722523

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Strawn, L. G., Flegal, K. M., & Mei, Z. (2002) · Cited by 6,426
2000 CDC Growth Charts for the United States: methods and development.
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Grummer‐Strawn, L. M., Flegal, K. M., Mei, Z., Wei, R. X., Curtin, L. R., Roche, A. F., & Johnson, C. L. (2002) · PubMed · Cited by 3,716
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,930
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620
Sources, fate and transport of perfluorocarboxylates
Prevedouros, K., Cousins, I. T., Buck, R. C., & Korzeniowski, S. H. (2006) · Environmental Science & Technology · doi:10.1021/es0512475 · Cited by 2,594
Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049
Polyfluorinated Compounds: Past, Present, and Future
Lindstrom, A. B., Strynar, M. J., & Libelo, E. L. (2011) · Environmental Science & Technology · doi:10.1021/es2011622 · Cited by 1,628
Physiological Parameter Values for Physiologically Based Pharmacokinetic Models
Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., & Beliles, R. P. (1997) · Toxicology and Industrial Health · doi:10.1177/074823379701300401 · Cited by 1,408
Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and Comparisons with NHANES 1999–2000
Calafat, A. M., Wong, L.-Y., Kuklenyik, Z., Reidy, J. A., & Needham, L. L. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10598 · Cited by 1,247
Organohalogen compounds
(1995) · Environmental Science and Pollution Research · doi:10.1007/bf02986737 · Cited by 1,126

Show all 109 references

Research works printed but not linked: 12

Apelberg B.J., 2007, Health. Perspect.115:1670.
Centers for Disease Control and Prevention, 2004, Morbid. Mortal Weekly Rep, 1971
Clewell H.J., 1999, Risk Anal., 19, 547
Ehresman D.J., 2007, Res., 103, 176
Gentry P.R., 2002, Toxicol. Pharmacol., 36, 51
Gentry P.R., 2003, Toxicol. Pharmacol., 38, 1
Kerstner-Wood C., 2003, Birmingham, AL: Southern Research Corporation.
Loccisano A.E., 2012, Toxicol., 33, 468
Milman N., 1999, Acta Obstet. Gynecol. Scand., 78, 749, 10.1080/j.1600-0412.1999.780902.x · DOI
Olsen G.W., 2009, Toxicol., 27, 212
Raymer J.H., 2012, Toxicol., 33, 419
Sisson T.R.C., 1959, J. Pediat., 55:163

Sorted by citations

Risk to human health related to the presence of perfluoroalkyl substances in food
Panel), E. P. O. C. I. T. F. C. (. C., Schrenk, D., Bignami, M., Bodin, L., Chipman, J. K., del Mazo, J., Grasl‐Kraupp, B., Hogstrand, C., Hoogenboom, L. (., Leblanc, J., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6223 · Cited by 989
Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food
(CONTAM), E. P. O. C. I. T. F. C., Knutsen, H. K., Alexander, J., Barregård, L., Bignami, M., Brüschweiler, B. J., Ceccatelli, S., Cottrill, B., Dinovi, M., Edler, L., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5194 · Cited by 549
Early Life Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Latent Health Outcomes: A Review Including the Placenta as a Target Tissue and Possible Driver of Peri- and Postnatal Effects
Blake, B. E., & Fenton, S. E. (2020) · Toxicology · doi:10.1016/j.tox.2020.152565 · Cited by 499
Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: A systematic review
Bach, C. C., Bech, B. H., Brix, N., Nohr, E. A., Bonde, J. P., & Henriksen, T. B. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.952400 · Cited by 311
Per- and polyfluorinated substances (PFASs): Environmental challenges
Krafft, M. P., & Riess, J. G. (2015) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2015.07.004 · Cited by 294
Molecular mechanisms of PFOA-induced toxicity in animals and humans: Implications for health risks
Li, K., Gao, P., Xiang, P., Zhang, X., Cui, X., & Ma, L. Q. (2016) · Environment International · doi:10.1016/j.envint.2016.11.014 · Cited by 268
Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK)
Verner, M.-A., Loccisano, A. E., Morken, N., Yoon, M., Wu, H., McDougall, R., Maisonet, M., Marcus, M., Kishi, R., Miyashita, C., et al. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1408837 · Cited by 251
Self-citation
The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Integration of Animal and Human Evidence for PFOA Effects on Fetal Growth
Lam, J., Koustas, E., Sutton, P., Johnson, P. I., Atchley, D. S., Sen, S., Robinson, K. A., Axelrad, D. A., & Woodruff, T. J. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307923 · Cited by 214
Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria
Pizzurro, D. M., Seeley, M., Kerper, L. E., & Beck, B. D. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.05.008 · Cited by 206
Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women
Brantsæter, A. L., Whitworth, K. W., Ydersbond, T. A., Haug, L. S., Haugen, M. A., Knutsen, H. K., Thomsen, C., Meltzer, H. M., Becher, G., Sabaredzovic, A., et al. (2013) · Environment International · doi:10.1016/j.envint.2012.12.014 · Cited by 199
Self-citation
Breastfeeding as an exposure pathway for perfluorinated alkylates
Mogensen, U. B., Grandjean, P., Nielsen, F., Weihe, P., & Budtz-Jørgensen, E. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b02237 · Cited by 190
Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study
Vélez, M. P., Arbuckle, T. E., & Fraser, W. D. (2015) · Human Reproduction · doi:10.1093/humrep/deu350 · Cited by 194
Perfluorinated Alkyl Substances
Grandjean, P., & Clapp, R. (2015) · NEW SOLUTIONS A Journal of Environmental and Occupational Health Policy · doi:10.1177/1048291115590506 · Cited by 189
A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans
Chang, E. T., Adami, H.-O., Boffetta, P., Cole, P., Starr, T. B., & Mandel, J. S. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.905767 · Cited by 180
Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study
Starling, A. P., Engel, S. M., Whitworth, K. W., Richardson, D. B., Stuebe, A. M., Daniels, J. L., Haug, L. S., Eggesbø, M. Å., Becher, G., Sabaredzovic, A., et al. (2013) · Environment International · doi:10.1016/j.envint.2013.10.004 · Cited by 174
Self-citation
Early life exposure to per- and polyfluoroalkyl substances (PFASs): a critical review
Winkens, K., Vestergren, R., Berger, U., & Cousins, I. T. (2017) · Emerging Contaminants · doi:10.1016/j.emcon.2017.05.001 · Cited by 145
Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy
Huang, R., Chen, Q., Zhang, L., Luo, K., Chen, L., Zhao, S., Feng, L., & Zhang, J. (2019) · Environmental Health · doi:10.1186/s12940-018-0445-3 · Cited by 145
Serum Perfluorooctanoic Acid and Birthweight
Steenland, K., Barry, V., & Savitz, D. A. (2018) · Epidemiology · doi:10.1097/ede.0000000000000903 · Cited by 133
A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics
Niu, S., Cao, Y., Chen, R., Bedi, M., Sanders, A. P., DUCATMAN, A. M., & Ng, C. A. (2023) · Environmental Health Perspectives · doi:10.1289/ehp11885 · Cited by 122
Comparing dietary and non-dietary source contribution of BPA and DEHP to prenatal exposure: A Catalonia (Spain) case study
Martínez, M. Á., Rovira, J., Sharma, R. P., Nadal, M., Schuhmacher, M., & Kumar, V. (2018) · Environmental Research · doi:10.1016/j.envres.2018.05.008 · Cited by 109
Relationships of Chemical Concentrations in Maternal and Cord Blood: A Review of Available Data
Aylward, L. L., Hays, S. M., Kirman, C. R., Marchitti, S. A., Kenneke, J. F., English, C. A., Mattison, D. R., & Becker, R. A. (2014) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2014.884956 · Cited by 105
Maternal plasma per- and polyfluoroalkyl substance concentrations in early pregnancy and maternal and neonatal thyroid function in a prospective birth cohort: project viva (USA)
Preston, E. V., Webster, T. F., Oken, E., Claus Henn, B., McClean, M. D., Rifas-Shiman, S. L., Pearce, E. N., Braverman, L. E., Calafat, A. M., Ye, X., et al. (2018) · Environmental Health Perspectives · doi:10.1289/ehp2534 · Cited by 105
The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis
Appel, M., Forsthuber, M., Ramos, R., Widhalm, R., Granitzer, S., Uhl, M., Hengstschläger, M., Stamm, T., & Gundacker, C. (2022) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2021.2009946 · Cited by 104
A Simple Pharmacokinetic Model of Prenatal and Postnatal Exposure to Perfluoroalkyl Substances (PFASs)
Verner, M.-A., Ngueta, G., Jensen, E. T., Fromme, H., Völkel, W., Nygaard, U. C., Granum, B. B., & Longnecker, M. P. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b04399 · Cited by 107
Self-citation
Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses
Zhang, Z., Imperial, M. Z., Patilea-Vrana, G., Wedagedera, J. R., Gaohua, L., & Unadkat, J. D. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.075192 · Cited by 103
Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? A workshop report on potential mechanisms
Andersen, M. E., Hagenbuch, B., Apte, U. M., Corton, J. C., Fletcher, T., Lau, C. S., Roth, W. L., Staels, B., Vega, G. L., M.A., H. J. C. I., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.152845 · Cited by 104
Self-citation
PBPK modeling for PFOS and PFOA: Validation with human experimental data
Fàbrega, F., Kumar, V., Schuhmacher, M., Domingo, J. L., & Nadal, M. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.007 · Cited by 103
Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the Model for Passive Placental Permeability Drugs
Zhang, Z., & Unadkat, J. D. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.073957 · Cited by 98
Principles of dose-setting in toxicology studies: the importance of kinetics for ensuring human safety
Borgert, C. J., Fuentes, C., & Burgoon, L. D. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03155-4 · Cited by 95
Occurrence of Major Perfluorinated Alkylate Substances in Human Blood and Target Organs
Nielsen, F., Fischer, F. C., Leth, P. M., & Grandjean, P. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c06499 · Cited by 95
Toxicokinetics of Seven Perfluoroalkyl Sulfonic and Carboxylic Acids in Pigs Fed a Contaminated Diet
Numata, J., Kowalczyk, J., Adolphs, J., Ehlers, S., Schafft, H., Fuerst, P., Müller-Graf, C., Lahrssen-Wiederholt, M., & Greiner, M. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf405827u · Cited by 92
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models
Mendes, M. D. S., Hirt, D., Vinot, C., Valade, E., Lui, G., Pressiat, C., Bouazza, N., Foissac, F., Blanche, S., Lê, M., et al. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12815 · Cited by 88
Perfluoroalkyl Acids in Maternal Serum and Indices of Fetal Growth: The Aarhus Birth Cohort
Bach, C. C., Bech, B. H., Nohr, E. A., Olsen, J., Matthiesen, N. B., Bonefeld‐Jørgensen, E. C., Bossi, R., & Henriksen, T. B. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1510046 · Cited by 94
Temporal Shifts in Poly- and Perfluoroalkyl Substances (PFASs) in North Atlantic Pilot Whales Indicate Large Contribution of Atmospheric Precursors
Dassuncao, C., Hu, X. C., Zhang, X., Bossi, R., Dam, M., Mikkelsen, B., & Sunderland, E. M. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b00293 · Cited by 90
Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and birth outcomes: a longitudinal cohort with repeated measurements
Chen, L., Tong, C., Huo, X., Zhang, J., & Tian, Y. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2020.128899 · Cited by 79
Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the project viva cohort
Preston, E. V., Hivert, M.-F., Fleisch, A. F., Calafat, A. M., Sagiv, S. K., Perng, W., Rifas-Shiman, S. L., Chavarro, J. E., Oken, E., Zota, A. R., et al. (2022) · Environment International · doi:10.1016/j.envint.2022.107335 · Cited by 78
Perfluoroalkyl Acids (PFAAs) in Serum from 2–4-Month-Old Infants: Influence of Maternal Serum Concentration, Gestational Age, Breast-Feeding, and Contaminated Drinking Water
Gyllenhammar, I., Benskin, J. P., Sandblom, O., Berger, U., Ahrens, L., Lignell, S., Wiberg, K., & Glynn, A. W. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b00770 · Cited by 75
Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal‐Fetal Drug Transfer
Dallmann, A., Liu, X. I., Burckart, G. J., & van den Anker, J. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1491 · Cited by 70
Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April – June 2009
Health Pr Collective Health Protection Agency (2009) · Eurosurveillance · doi:10.2807/ese.14.22.19232-en · Cited by 70
A Simplified PBPK Modeling Approach for Prediction of Pharmacokinetics of Four Primarily Renally Excreted and CYP3A Metabolized Compounds During Pregnancy
Xia, B., Heimbach, T., Gollen, R., Nanavati, C., & He, H. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9505-3 · Cited by 68
The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data
Sharma, R. P., Schuhmacher, M., & Kumar, V. (2018) · Science of The Total Environment · doi:10.1016/j.scitotenv.2017.12.023 · Cited by 68
The effects of perfluoroalkyl and polyfluoroalkyl substances on female fertility: A systematic review and meta-analysis
Wang, W., Hong, X., Zhao, F., Wu, J., & Wang, B. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114718 · Cited by 66
Current Breast Milk PFAS Levels in the United States and Canada: After All This Time, Why Don’t We Know More?
LaKind, J. S., Verner, M.-A., Rogers, R. D., Goeden, H. M., Naiman, D. Q., Marchitti, S. A., Lehmann, G. M., Hines, E. P., & Fenton, S. E. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10359 · Cited by 68
Association between Perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study
Wang, Y., Starling, A. P., Haug, L. S., Eggesbø, M. Å., Becher, G., Thomsen, C., Travlos, G. S., King, D., Hoppin, J. A., Rogan, W. J., et al. (2013) · Environmental Health · doi:10.1186/1476-069x-12-76 · Cited by 64
Self-citation
A transgenerational toxicokinetic model and its use in derivation of Minnesota PFOA water guidance
Goeden, H. M., Greene, C. W., & Jacobus, J. A. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0110-5 · Cited by 59
Perfluoroalkyl Substances and Maternal Thyroid Hormones in Early Pregnancy; Findings in the Danish National Birth Cohort
Inoue, K., Ritz, B. R., Andersen, S. L., Ramlau‐Hansen, C. H., Høyer, B. B., Bech, B. H., Henriksen, T. B., Bonefeld‐Jørgensen, E. C., Olsen, J., & Liew, Z. (2019) · Environmental Health Perspectives · doi:10.1289/ehp5482 · Cited by 60
Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model
Kim, S., Choi, E.-J., Choi, G.-W., Lee, Y., & Cho, H. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2365-y · Cited by 53
Improving the risk assessment of lipophilic persistent environmental chemicals in breast milk
Lehmann, G. M., Verner, M.-A., Luukinen, B., Henning, C. C., Assimon, S. A., LaKind, J. S., McLanahan, E. D., Phillips, L. J., Davis, M. H., Powers, C. M., et al. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.926306 · Cited by 52
Self-citation
Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values
Chou, W., & Lin, Z. (2021) · Environmental Health Perspectives · doi:10.1289/ehp7671 · Cited by 52
Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models
Chaphekar, N., Dodeja, P., Shaik, I. H., Caritis, S. N., & Venkataramanan, R. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.733823 · Cited by 50
Neurotoxic effects of lactational exposure to perfluorooctane sulfonate on learning and memory in adult male mouse
Mshaty, A., Haijima, A., Takatsuru, Y., Ninomiya, A., Yajima, H., Kokubo, M., Khairinisa, M. A., Miyazaki, W., Amano, I., & Koibuchi, N. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111710 · Cited by 50
Integration of Life-Stage Physiologically Based Pharmacokinetic Models with Adverse Outcome Pathways and Environmental Exposure Models to Screen for Environmental Hazards
El-Masri, H. A., Kleinstreuer, N., Hines, R. N., Adams, L. D., Tal, T. L., Isaacs, K., Wetmore, B. A., & Tan, Y. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw082 · Cited by 47
Perfluoroalkyl Acids (PFAAs) in Children’s Serum and Contribution from PFAA-Contaminated Drinking Water
Gyllenhammar, I., Benskin, J. P., Sandblom, O., Berger, U., Ahrens, L., Lignell, S., Wiberg, K., & Glynn, A. W. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b01746 · Cited by 54
Quantitative bias analysis for epidemiological associations of perfluoroalkyl substance serum concentrations and early onset of menopause
Ruark, C. D., Song, G. K., Yoon, M., Verner, M.-A., Andersen, M. E., M.A., H. J. C. I., & Longnecker, M. P. (2016) · Environment International · doi:10.1016/j.envint.2016.11.030 · Cited by 50
Self-citation
Probabilistic Physiologically Based Pharmacokinetic Model for Penicillin G in Milk From Dairy Cows Following Intramammary or Intramuscular Administrations
Li, M., Gehring, R., Riviere, J. E., & Lin, Z. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy067 · Cited by 45
Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function
Nielsen, C., Andersson-Hall, U. K., Lindh, C. H., Ekström, U., Xu, Y., Li, Y., Holmäng, A. B., & Jakobsson, K. (2020) · Environmental Health · doi:10.1186/s12940-020-00626-6 · Cited by 45
Perfluoroalkyl substance excretion: effects of organic anion-inhibiting and resin-binding drugs in a community setting
Ducatman, A., Luster, M., & Fletcher, T. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103650 · Cited by 42
Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model
Kim, S., Shin, H., Lee, Y., & Cho, H. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2116-5 · Cited by 50
Methodological Approaches to Evaluate Fetal Drug Exposure
Bouazza, N., Foissac, F., Hirt, D., Urien, S., Benaboud, S., Lui, G., & Tréluyer, J. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190319102812 · Cited by 42
Placental Transfer and Composition of Perfluoroalkyl Substances (PFASs): A Korean Birth Panel of Parent-Infant Triads
Kang, H., Kim, H., Yoon, Y. S., Lee, J., Kho, Y., Lee, J., Chang, H., Cho, Y. H., & Kim, Y. A. (2021) · Toxics · doi:10.3390/toxics9070168 · Cited by 42
Toxicokinetics of perfluorooctane sulfonate in birds under environmentally realistic exposure conditions and development of a kinetic predictive model
Tarazona, J. V., Rodríguez, C., Alonso, E., Sáez, M. R., Gonzalez, F. J., Andrés, M. D. S., Jiménez, B., & Andrés, M. I. S. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.11.022 · Cited by 43
Infant toxicology: State of the science and considerations in evaluation of safety
Neal-Kluever, A., Aungst, J. L., Gu, Y. H., Hatwell, K. R., Muldoon‐Jacobs, K., Liem, A., Ogungbesan, A., & Shackelford, M. E. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.05.003 · Cited by 40
Investigation of the Effects of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) on Apoptosis and Cell Cycle in a Zebrafish (Danio rerio) Liver Cell Line
Cui, Y., Liu, W., Xie, W., Yu, W., Wang, C., & Chen, H. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph121215012 · Cited by 39
Stranded cetaceans warn of high perfluoroalkyl substance pollution in the western Mediterranean Sea
López-Berenguer, G., Bossi, R., Eulaers, I., Dietz, R., Peñalver, J., Schulz, R., Zubrod, J. P., Sonne, C., & Martínez-López, E. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115367 · Cited by 40
Prediction of maternal and foetal exposures to perfluoroalkyl compounds in a Spanish birth cohort using toxicokinetic modelling
Brochot, C., Casas, M., Manzano-Salgado, C. B., Zeman, F., Schettgen, T., Vrijheid, M., & Bois, F. Y. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114640 · Cited by 42
Risk Assessment of Perfluorooctane Sulfonate (PFOS) using Dynamic Age Dependent Physiologically based Pharmacokinetic Model (PBPK) across Human Lifetime
Deepika, D., Sharma, R. P., Schuhmacher, M., & Kumar, V. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111287 · Cited by 41
Pregnancy-related maternal physiological adaptations and fetal chemical exposure
Vinnars, M.-T., Bixo, M., & Damdimopoulou, P. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112064 · Cited by 32
Distinct transcriptional response of Caenorhabditis elegans to different exposure routes of perfluorooctane sulfonic acid
Stylianou, M., Björnsdotter, M. K., Olsson, P., Jogsten, I. E., & Jaß, J. (2018) · Environmental Research · doi:10.1016/j.envres.2018.10.019 · Cited by 30
Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative
Sarigiannis, D. A., Karakitsios, S., Domínguez-Romero, E., Papadaki, K., Brochot, C., Kumar, V., Schuhmacher, M., Sy, M. M., Mielke, H., Greiner, M., et al. (2019) · Environmental Research · doi:10.1016/j.envres.2019.01.045 · Cited by 33
Mechanistic Middle-Out Physiologically Based Toxicokinetic Modeling of Transporter-Dependent Disposition of Perfluorooctanoic Acid in Humans
Lin, J., Chin, S. Y., Tan, S. P. F., Koh, H. C., Cheong, E. J. Y., Chan, E. C. Y., & Chan, J. C. Y. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.2c05642 · Cited by 26
Development of a Physiologically Based Pharmacokinetic (PBPK) Model for F-53B in Pregnant Mice and Its Extrapolation to Humans
Zhang, J., Li, S.-P., Li, Q., Zhang, Y., Dong, G., Canchola, A., Zeng, X., & Chou, W. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c05405 · Cited by 26
Outcome of a public consultation on the draft risk assessment of perfluoroalkyl substances in food
(EFSA), E. F. S. A. (2020) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2020.en-1931 · Cited by 29
NTP Technical Report on the Toxicology and Carcinogenesis Studies of Perfluorooctanoic Acid (CASRN 335-67-1) Administered in Feed to Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats
(NTP), N. T. P. (2020) · doi:10.22427/ntp-tr-598 · Cited by 27
Metabolism and Pharmacokinetics
Kudo, N. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15518-0_6 · Cited by 27
The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy
Zuanna, T. D., Savitz, D. A., Barbieri, G., Pitter, G., Jeddi, M. Z., Daprà, F., Fabricio, A. S. C., Russo, F., Fletcher, T., & Canova, C. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111805 · Cited by 28
Placental transfer of xenobiotics in pregnancy physiologically-based pharmacokinetic models: Structure and data
Codaccioni, M., Bois, F. Y., & Brochot, C. (2019) · Computational Toxicology · doi:10.1016/j.comtox.2019.100111 · Cited by 24
N-acetyl cysteine abates hepatorenal toxicities induced by perfluorooctanoic acid exposure in male rats
Owumi, S. E., Bello, T., & Oyelere, A. K. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103667 · Cited by 24
PFASs in the General Population
Kato, K., Ye, X., & Calafat, A. M. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15518-0_3 · Cited by 23
Perfluorooctane sulfonate exacerbates mast cell-mediated allergic inflammation by the release of histamine
Lee, J., Lee, S., Choi, Y., Jin, M., Kim, Y.-Y., Kang, B.-C., Kim, M.-J., Dhakal, H., Lee, S., Kim, S.-U., et al. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-018-0019-z · Cited by 22
Health risk assessment of perfluorooctane sulfonate and perfluorooctanoic acid exposure in China based on epidemiological data
Zhang, Y.-T., Bao, H., Zhang, L., Wen, S., Tan, W., Zeeshan, M., Sun, M.-K., Chu, C., Gui, Z., Lin, L., et al. (2023) · Hygiene and Environmental Health Advances · doi:10.1016/j.heha.2023.100066 · Cited by 22
Dynamic exposure and body burden models for per- and polyfluoroalkyl substances (PFAS) enable management of food safety risks in cattle
Mikkonen, A., Martin, J., Upton, R. N., Moenning, J.-L., Numata, J., Taylor, M. P., Roberts, M. S., & Mackenzie, L. (2023) · Environment International · doi:10.1016/j.envint.2023.108218 · Cited by 23
Physiologically based pharmacokinetic modeling of perfluoroalkyl substances in the human body
Fàbrega, F., Kumar, V., Benfenati, E., Schuhmacher, M., Domingo, J. L., & Nadal, M. (2015) · Toxicological & Environmental Chemistry Reviews · doi:10.1080/02772248.2015.1060976 · Cited by 22
Assessing the impacts on fetal dosimetry of the modelling of the placental transfers of xenobiotics in a pregnancy physiologically based pharmacokinetic model
Codaccioni, M., & Brochot, C. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115318 · Cited by 23
Children's exposure to perfluoroalkyl acids – a modelling approach
Balk, F., Pütz, K. W., Ribbenstedt, A., Gomis, M. I., Filipovic, M., & Cousins, I. T. (2019) · Environmental Science Processes & Impacts · doi:10.1039/c9em00323a · Cited by 22
Studying mixture effects on uptake and tissue distribution of PFAS in zebrafish (Danio rerio) using physiologically based kinetic (PBK) modelling
Golosovskaia, E., Örn, S., Ahrens, L., Chelcea, I., & Andersson, P. L. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168738 · Cited by 21
Extensive literature search and provision of summaries of studies related to the oral toxicity of perfluoroalkylated substances (PFASs), their precursors and potential replacements in experimental animals and humans. Area 1: Data on toxicokinetics (absorption, distribution, metabolism, excretion) in in vitro studies, experimental animals and humans. Area 2: Data on toxicity in experimental animals. Area 3: Data on observations in humans
Bull, S., Burnett, K., Vassaux, K., Ashdown, L., Brown, T., & Rushton, L. (2014) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2014.en-572 · Cited by 20
Brief Report
Whitworth, K. W., Haug, L. S., Sabaredzovic, A., Eggesbø, M. Å., & Longnecker, M. P. (2016) · Epidemiology · doi:10.1097/ede.0000000000000524 · Cited by 18
Self-citation
Estimation of species- and sex-specific PFAS pharmacokinetics in mice, rats, and non-human primates using a Bayesian hierarchical methodology
Zurlinden, T. J., Dzierlenga, M. W., Kapraun, D. F., Ring, C., Bernstein, A. S., Schlosser, P. M., & Morozov, V. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117336 · Cited by 17
Development and application of an interactive generic physiologically based pharmacokinetic (igPBPK) model for adult beef cattle and lactating dairy cows to estimate tissue distribution and edible tissue and milk withdrawal intervals for per- and polyfluoroalkyl substances (PFAS)
Chou, W., Tell, L. A., Baynes, R. E., Davis, J. L., Cheng, Y., Maunsell, F. P., Riviere, J. E., & Lin, Z. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114062 · Cited by 18
Physiologically-based pharmacokinetic modelling of infant exposure to efavirenz through breastfeeding
Olagunju, A., Rajoli, R. K. R., Atoyebi, S., Khoo, S., Owen, A., & Siccardi, M. (2018) · AAS Open Research · doi:10.12688/aasopenres.12860.1 · Cited by 17
Reconstruction of phthalate exposure and DINCH metabolites from biomonitoring data from the EXHES cohort of Tarragona, Spain: A case study on estimated vs reconstructed DEHP using the PBPK model
Martínez, M. Á., Rovira, J., Sharma, R. P., Schuhmacher, M., & Kumar, V. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109534 · Cited by 17
N‐acetyl cysteine co‐treatment abates perfluorooctanoic acid‐induced reproductive toxicity in male rats
Owumi, S. E., Akomolafe, A. P., Imosemi, I. O., Odunola, O. A., & Oyelere, A. K. (2021) · Andrologia · doi:10.1111/and.14037 · Cited by 17
Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures
Andersen, M. E., Mallick, P., M.A., H. J. C. I., Yoon, M., Olsen, G. W., & Longnecker, M. P. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111183 · Cited by 17
Self-citation
Negligible Pharmacokinetic Interaction of Red Ginseng and Antihypertensive Agent Amlodipine in Sprague-Dawley Rats
Ryu, S. H., Kim, J. W., Kim, Y. S., Lee, S., Cho, Y.-B., Lee, H. K., Kim, Y. G., Jeong, W., & Kim, K. (2014) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2014.951594 · Cited by 17
Estimating the Dynamic Early Life Exposure to PFOA and PFOS of the HELIX Children: Emerging Profiles via Prenatal Exposure, Breastfeeding, and Diet
Ratier, A., Casas, M., Grazuleviciene, R., Slama, R., Småstuen Haug, L., Thomsen, C., Vafeiadi, M., Wright, J., Zeman, F. A., Vrijheid, M., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108621 · Cited by 16
Development of a physiologically based toxicokinetic model for lead in pregnant women: The role of bone tissue in the maternal and fetal internal exposure
Daoud, Y. A., Tebby, C., Beaudouin, R., & Brochot, C. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116651 · Cited by 17
Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project Population
Avanasi, R., Shin, H.-M., Vieira, V., & Bartell, S. (2016) · Environmental Research · doi:10.1016/j.envres.2016.01.011 · Cited by 15
Toxicokinetics of perfluorooctane sulfonate in rabbits under environmentally realistic exposure conditions and comparative assessment between mammals and birds.
Tarazona, J. V., Rodríguez, C., Alonso, E., Sáez, M. R., Gonzalez, F. J., Andrés, M. D. S., Jiménez, B., & Andrés, M. I. S. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.11.002 · Cited by 15
Data derived Extrapolation Factors for developmental toxicity: A preliminary research case study with perfluorooctanoate (PFOA)
Dourson, M. L., Gadagbui, B. K.-M., Onyema, C., McGinnis, P. M., & York, R. G. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104446 · Cited by 15
Community-facing toxicokinetic models to estimate PFAS serum levels based on life history and drinking water exposures
Lynch, M. T., Lay, C. R., Sokolinski, S., Antezana, A., Ghio, C., Chiu, W. A., & Rogers, R. D. (2023) · Environment International · doi:10.1016/j.envint.2023.107974 · Cited by 15

Authors: Loccisano, A. E., Longnecker, M. P., Campbell, J. L., Andersen, M. E., & Clewell, H. J.
Affiliations: The Hamner Institutes for Health Sciences (US)
National Institutes of Health (US)
Center for Human Health Assessment, The Hamner Institutes for Health Sciences , Research Triangle Park, North Carolina, USA
Corresponding author: Loccisano, Anne E.
ORCID: Loccisano, Anne E.
Longnecker, Matthew P.
Campbell, Jerry L.
Andersen, Melvin E.
Venue: Journal of Toxicology and Environmental Health, Part A
Publisher: Informa UK Limited
Published: 2012-11-14
Volume: 76
Issue: 1
Pages: 25-57
ISSN: 0098-4108 (ISSN-L)
1528-7394
1087-2620
DOI: 10.1080/15287394.2012.722523
PMC: PMC3502013
OpenAlex: W2049985148
Cited by: 141
References: 109
Citations by year: 2026: 6 · 2025: 8 · 2024: 8 · 2023: 17 · 2022: 4 · 2021: 12 · 2020: 13 · 2019: 13 · 2018: 12 · 2017: 11 · 2016: 5 · 2015: 14 · 2014: 11 · 2013: 5
FWCI: 7.68
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Toxicology and Environmental Health (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute of Environmental Health Sciences (ZIAES044008)
Topics: Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
Keywords: perfluorooctanoic acid, PFOS, perfluoroalkyl acids, physiologically based pharmacokinetic modeling, human pregnancy, lactation, fetal pharmacokinetics, maternal exposure, milk concentration, clearance, developmental toxicity
MeSH terms: Adult, Animals, Haplorhini, Caprylates, Computer Simulation, Female, Fluorocarbons, Humans, Infant, Newborn, Kidney, Lactation, Maternal-Fetal Exchange, Models, Biological, Pregnancy, Protein Binding, Risk Factors, Alkanesulfonic Acids, Maternal Exposure, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development of Pbpk Models for Pfoa and Pfos for Human Pregnancy and Lactation Life Stages

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks